{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:49:21Z","timestamp":1774885761269,"version":"3.50.1"},"reference-count":125,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Janssen Pharmaceutica"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.drudis.2020.06.011","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T11:29:40Z","timestamp":1592220580000},"page":"1362-1373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["pH-dependent ileocolonic drug delivery, part I: in vitro and clinical evaluation of novel systems"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8231-9549","authenticated-orcid":false,"given":"Annemarie","family":"Broesder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman J.","family":"Woerdenbag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grietje H.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duong N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7901-8198","authenticated-orcid":false,"given":"Henderik W.","family":"Frijlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1481-2769","authenticated-orcid":false,"given":"Wouter L.J.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2020.06.011_bib0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.addr.2004.08.011","article-title":"New oral delivery systems for treatment of inflammatory bowel disease","volume":"57","author":"Friend","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2020.06.011_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.addr.2016.02.004","article-title":"Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials","volume":"106","author":"Aguirre","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2020.06.011_bib0015","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1517\/17425247.2015.1060217","article-title":"Colon: a gateway for chronotherapeutic drug delivery systems","volume":"12","author":"Patel","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.drudis.2020.06.011_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2018.01.003","article-title":"Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosa","volume":"272","author":"Sharma","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2020.06.011_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/pharmaceutics12010068","article-title":"Strategic approaches for colon targeted drug delivery: an overview of recent advancements","volume":"12","author":"Lee","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2020.06.011_bib0030","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jps.21502","article-title":"Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states","volume":"98","author":"Clarysse","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejps.2009.10.005","article-title":"Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption","volume":"39","author":"Annaert","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0040","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1211\/jpp.58.8.0009","article-title":"Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum","volume":"58","author":"Perez de la Cruz Moreno","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11095-005-8476-1","article-title":"Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability\/bioequivalence studies","volume":"23","author":"Kalantzi","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0050","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ejpb.2013.05.007","article-title":"Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities","volume":"85","author":"Pedersen","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/gut.17.2.133","article-title":"Effect of cimetidine on 24-hour intragastric acidity in normal subjects","volume":"17","author":"Pounder","year":"1976","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2020.06.011_bib0060","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s11095-011-0506-6","article-title":"Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults","volume":"28","author":"Psachoulias","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0065","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jps.20553","article-title":"Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: A case study with amprenavir","volume":"95","author":"Brouwers","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jps.24603","article-title":"Characterization of human duodenal fluids in fasted and fed state conditions","volume":"105","author":"Riethorst","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0075","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1007\/s11095-015-1710-6","article-title":"Characterization of contents of distal ileum and cecum to which drugs\/drug products are exposed during bioavailability\/bioequivalence studies in healthy adults","volume":"32","author":"Reppas","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0080","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-009-9927-x","article-title":"Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults","volume":"26","author":"Diakidou","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0085","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/0016-5085(85)90009-5","article-title":"Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists","volume":"88","author":"Fimmel","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2020.06.011_bib0090","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/0016-5085(86)90873-5","article-title":"Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency","volume":"90","author":"Ovesen","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2020.06.011_bib0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1023\/A:1015827908309","article-title":"Upper gastrointestinal (GI) pH in young, healthy men and women","volume":"7","author":"Dressman","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCG.0b013e31818e37ab","article-title":"Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system","volume":"43","author":"Bratten","year":"2009","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0105","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1007\/s10620-005-3048-0","article-title":"Regional postprandial differences in pH within the stomach and gastroesophageal junction","volume":"50","author":"Simonian","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0110","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/BF01535781","article-title":"24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry","volume":"33","author":"Savarino","year":"1988","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0115","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00004836-200608000-00010","article-title":"Postprandial stomach contents have multiple acid layers","volume":"40","author":"Hila","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1018970323716","article-title":"Upper gastrointestinal pH in seventy-nine healthy, elderly North American men and women","volume":"10","author":"Russell","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2016.09.009","article-title":"Resolving the physiological conditions in bioavailability and bioequivalence studies: Comparison of fasted and fed state","volume":"108","author":"Schneider","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0130","first-page":"211","article-title":"Measurement of gastrointestinal pH and regional transit times in normal children","volume":"11","author":"Fallingborg","year":"1990","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.drudis.2020.06.011_bib0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2036.1990.tb00469.x","article-title":"Gastrointestinal pH and transit times in healthy subjects with ileostomy","volume":"4","author":"Fallingborg","year":"1990","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129076","article-title":"Gastrointestinal pH and transit time profiling in healthy volunteers using the IntelliCap system confirms ileocolonic release of ColoPulse tablets","volume":"10","author":"Maurer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.06.011_bib0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jps.2600750313","article-title":"Comparison of gastrointestinal pH in dogs and humans: Implications on the use of the Beagle dog as a model for oral absorption in humans","volume":"75","author":"Lui","year":"1986","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0150","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s11095-008-9580-9","article-title":"Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileocolonic release systems","volume":"25","author":"Ibekwe","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0155","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/jps.24274","article-title":"Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap\u00ae system","volume":"104","author":"Koziolek","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0160","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1023\/A:1018893409596","article-title":"Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn\u2019s disease","volume":"43","author":"Fallingborg","year":"1998","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1365-2036.1998.00358.x","article-title":"Gastrointestinal pH profiles in patients with inflammatory bowel disease","volume":"12","author":"Press","year":"1998","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0170","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2036.1989.tb00254.x","article-title":"pH-Profile and regional transit times of the normal gut measured by a radiotelemetry device","volume":"3","author":"Fallingborg","year":"1989","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0175","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/gut.31.12.1355","article-title":"Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma","volume":"31","author":"Pye","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2020.06.011_bib0180","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1023\/A:1026664105112","article-title":"Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease","volume":"44","author":"Ewe","year":"1999","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0185","first-page":"G1276","article-title":"Accurate localization of a fall in pH within the ileocecal region: validation using a dual-scintigraphic technique","volume":"299","author":"Zarate","year":"2010","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0190","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of gastrointestinal pH profiles in normal ambulant human subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2020.06.011_bib0195","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1023\/A:1015998708560","article-title":"Gastrointestinal transit of a solid indigestible capsule as measured by radiotelemetry and dual gamma scintigraphy","volume":"6","author":"Mojaverian","year":"1989","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0200","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1023\/A:1015922903843","article-title":"Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerations","volume":"5","author":"Mojaverian","year":"1988","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2015.10.022","article-title":"Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies","volume":"220","author":"Koziolek","year":"2015","journal-title":"J. Control. Release."},{"key":"10.1016\/j.drudis.2020.06.011_bib0210","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s10620-009-0899-9","article-title":"Wireless capsule motility: Comparison of the SmartPill\u00ae GI monitoring system with scintigraphy for measuring whole gut transit","volume":"54","author":"Maqbool","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0215","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.22","article-title":"Assessment of tandem measurements of pH and total gut transit time in healthy volunteers","volume":"6","author":"Mikolajczyk","year":"2015","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0220","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.3748\/wjg.v20.i17.5000","article-title":"Caecal pH is a biomarker of excessive colonic fermentation","volume":"20","author":"Farmer","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0225","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/gut.15.12.999","article-title":"Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device","volume":"15","author":"Bown","year":"1974","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2020.06.011_bib0230","article-title":"Heidelberg capsule I. In vitro evaluation of a new instrument for measuring intragastric pH","volume":"54","author":"Steinberg","year":"1965","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0235","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000092885","article-title":"Ambulatory esophageal pH monitoring: new directions","volume":"24","author":"Dickman","year":"2006","journal-title":"Dig. Dis."},{"key":"10.1016\/j.drudis.2020.06.011_bib0240","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.gie.2005.07.007","article-title":"ASGE Technology Status Evaluation Report: wireless esophageal pH monitoring system","volume":"62","author":"Chotiprashidi","year":"2005","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.drudis.2020.06.011_bib0245","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1208\/s12249-014-0172-1","article-title":"Novel orally swallowable IntelliCap\u00ae device to quantify regional drug absorption in human GI tract using diltiazem as model drug","volume":"15","author":"Becker","year":"2014","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.drudis.2020.06.011_bib0250","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.gie.2013.03.170","article-title":"A novel ingestible electronic drug delivery and monitoring device","volume":"78","author":"van der Schaar","year":"2013","journal-title":"Gastrointest Endosc."},{"key":"10.1016\/j.drudis.2020.06.011_bib0255","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cgh.2009.01.017","article-title":"Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation","volume":"7","author":"Rao","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0260","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2036.2005.02489.x","article-title":"The effect of rabeprazole on regional gastric acidity and the postprandial cardia\/gastro-oesophageal junction acid layer in normal subjects: a randomized, double-blind, placebo-controlled study","volume":"21","author":"Vo","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0265","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2672.1991.tb02739.x","article-title":"The control and consequences of bacterial fermentation in the human colon","volume":"70","author":"Cummings","year":"1991","journal-title":"J. Appl. Bacteriol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0270","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jama.1997.03550080069041","article-title":"Gastric acidity in older adults","volume":"278","author":"Hurwitz","year":"1997","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drudis.2020.06.011_bib0275","first-page":"G1384","article-title":"Differences in intragastric pH in diabetic vs. idiopathic gastroparesis: relation to degree of gastric retention","volume":"294","author":"Hasler","year":"2008","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0280","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpharm.2005.10.038","article-title":"A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileocolonic delivery","volume":"308","author":"Ibekwe","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.03.009","article-title":"In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media","volume":"93","author":"Markopoulos","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0290","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejpb.2011.01.001","article-title":"Evolution of a physiological pH 6.8 bicarbonate buffer system: Application to the dissolution testing of enteric coated products","volume":"78","author":"Liu","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0295","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2009.08.003","article-title":"Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems","volume":"382","author":"Fadda","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0300","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/jps.20742","article-title":"An investigation into the in vivo performance variability of pH responsive polymers for ileocolonic drug delivery using gamma scintigraphy in humans","volume":"95","author":"Ibekwe","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0305","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1773-2247(05)50049-2","article-title":"Dissolution of pH responsive formulations in media resembling intestinal fluids: bicarbonate versus phosphate buffers","volume":"15","author":"Fadda","year":"2005","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0310","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejpb.2019.06.006","article-title":"Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer","volume":"142","author":"Amaral Silva","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0315","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejps.2013.09.020","article-title":"A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds","volume":"51","author":"Garbacz","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0320","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/jphp.12777","article-title":"Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tablets","volume":"69","author":"Karkossa","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0325","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2015.03.001","article-title":"Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state","volume":"75","author":"Pi\u0161lar","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0330","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1208\/s12248-016-9953-7","article-title":"A quantitative review and meta-models of the variability and factors affecting oral drug absorption\u2014part II: gastrointestinal transit time","volume":"18","author":"Abuhelwa","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.drudis.2020.06.011_bib0335","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/gut.27.8.886","article-title":"Transit of pharmaceutical dosage forms through the small intestine","volume":"27","author":"Davis","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2020.06.011_bib0340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2010.04.045","article-title":"The transit of dosage forms through the small intestine","volume":"395","author":"Yuen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0345","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11095-008-9749-2","article-title":"Meal-induced acceleration of tablet transit through the human small intestine","volume":"26","author":"Fadda","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0350","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1023\/A:1015849700421","article-title":"Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects","volume":"8","author":"Coupe","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2020.06.011_bib0355","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00006231-199003000-00003","article-title":"Fractional gastrointestinal transit time: intra- and interindividual variation","volume":"11","author":"Birkebaek","year":"1990","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.drudis.2020.06.011_bib0360","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.xphs.2018.02.016","article-title":"A biopredictive in vitro comparison of oral locally acting mesalazine formulations by a novel dissolution model for assessing intraluminal drug release in individual subjects","volume":"107","author":"Karkossa","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0365","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1080\/10408398.2017.1421900","article-title":"Can dynamic in vitro digestion systems mimic the physiological reality?","volume":"59","author":"Dupont","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.drudis.2020.06.011_bib0370","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.2174\/1381612043383476","article-title":"Radionuclide imaging in drug development","volume":"10","author":"Perkins","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drudis.2020.06.011_bib0375","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2125.1982.tb01999.x","article-title":"An oral preparation to release drugs in the human colon","volume":"14","author":"Dew","year":"1982","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0380","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1139\/H09-090","article-title":"A combination of pH-sensitive caplet coatings may be an effective noninvasive strategy to deliver bioactive substances, nutrients, or their precursors to the colon","volume":"34","author":"Aimone","year":"2009","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.drudis.2020.06.011_bib0385","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.2003.01445.x","article-title":"Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation","volume":"17","author":"Brunner","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0390","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1365-2036.2003.01558.x","article-title":"Combined scintigraphic and pharmacokinetic investigation of enteric-coated mesalazine micropellets in healthy subjects","volume":"17","author":"Wilding","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0395","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2036.2006.02721.x","article-title":"5-aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers","volume":"23","author":"Brunner","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0400","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(01)00871-7","article-title":"Enteric coated HPMC capsules designed to achieve intestinal targeting","volume":"231","author":"Cole","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2125.2005.02517.x","article-title":"Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation","volume":"61","author":"Brunner","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0410","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/jps.20063","article-title":"Scintigraphic evaluation of a novel colon-targeted delivery system (CODESTM) in healthy volunteers","volume":"93","author":"Katsuma","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0415","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0378-5173(94)90355-7","article-title":"The in vivo behaviour of a colonic delivery system: a pilot study in man","volume":"112","author":"Steed","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0420","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejpb.2013.01.002","article-title":"A novel coating concept for ileocolonic drug targeting: proof of concept in humans using scintigraphy","volume":"84","author":"Varum","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0425","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1046\/j.1365-2036.2003.01564.x","article-title":"Gastrointestinal transit and release of 5-aminosalicylic acid from 153 Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers","volume":"17","author":"Brunner","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0430","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/jps.22406","article-title":"Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma","volume":"100","author":"Patel","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0435","series-title":"E-Z-Paque 96 % w\/w Powder for Oral Suspension - Summary of Product Characteristics","author":"Bracco UK Limited","year":"2019"},{"key":"10.1016\/j.drudis.2020.06.011_bib0440","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2036.1987.tb00627.x","article-title":"Evaluation of an enteric-coated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease","volume":"1","author":"Hardy","year":"1987","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0445","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2003.01426.x","article-title":"A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules","volume":"17","author":"Edsb\u00e4cker","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0450","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2003.08.019","article-title":"Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome","volume":"93","author":"Xing","year":"2003","journal-title":"J. Control. Release."},{"key":"10.1016\/j.drudis.2020.06.011_bib0455","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00042737-200212000-00012","article-title":"Gut delivery of budesonide, a locally active corticosteroid, from plain and controlled-release capsules","volume":"14","author":"Edsb\u00e4cker","year":"2002","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0460","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.1987.tb00620.x","article-title":"Gastrointestinal transit of an enteric-coated delayed-release 5-aminosalicylic acid tablet","volume":"1","author":"Hardy","year":"1987","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0465","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-409X(00)00135-6","article-title":"The role of \u03b3-scintigraphy in oral drug delivery","volume":"46","author":"Wilding","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2020.06.011_bib0470","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2004.02.023","article-title":"Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans","volume":"97","author":"Goto","year":"2004","journal-title":"J. Control. Release."},{"key":"10.1016\/j.drudis.2020.06.011_bib0475","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2008.05.022","article-title":"An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man","volume":"130","author":"McConnell","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2020.06.011_bib0480","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2125.1979.tb04723.x","article-title":"A pharmacological method of measuring mouth caecal transit time in man","volume":"8","author":"Kennedy","year":"1979","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0485","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0168-3659(99)00005-X","article-title":"Evaluation of colonic absorbability of drugs in dogs using a novel colon-targeted delivery capsule (CTDC)","volume":"59","author":"Ishibashi","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2020.06.011_bib0490","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2036.2004.02033.x","article-title":"In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system","volume":"20","author":"Bott","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0495","first-page":"G371","article-title":"Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting","volume":"297","author":"Dahan","year":"2009","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0500","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cpt1973145802","article-title":"Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis; Effects of colectomy and of phenobarbital","volume":"14","author":"Schr\u00f4der","year":"1973","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0505","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0016-5085(86)90574-3","article-title":"Sulfapyridine appearance in plasma after salicylazosulfapyridine","volume":"91","author":"Kellow","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2020.06.011_bib0510","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1080\/10408398.2018.1461607","article-title":"Pharmacological potential of methylxanthines: retrospective analysis and future expectations","volume":"59","author":"Monteiro","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.drudis.2020.06.011_bib0515","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0009-9236(95)90217-1","article-title":"Orocecal transit time in humans assessed by sulfapyridine appearance in saliva after sulfasalazine intake","volume":"57","author":"Dh\u00f4te","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0520","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2019.10.023","article-title":"In vivo characterization of enTRinsicTM drug delivery technology capsule after intake in fed state: A cross-validation approach using salivary tracer technique in comparison to MRI","volume":"313","author":"Sager","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2020.06.011_bib0525","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2008.08.008","article-title":"Pulsatile drug delivery to ileocolonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings","volume":"132","author":"Schellekens","year":"2008","journal-title":"J. Control. Release."},{"key":"10.1016\/j.drudis.2020.06.011_bib0530","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2036.2005.02323.x","article-title":"In vivo evaluation of a colonic delivery system using isotope techniques","volume":"21","author":"Verbeke","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0535","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/10256016.2013.803099","article-title":"Isotope-labelled urea to test colon drug delivery devices in vivo : principles, calculations and interpretations","volume":"49","author":"Maurer","year":"2013","journal-title":"Isotopes Environ. Health Stud."},{"key":"10.1016\/j.drudis.2020.06.011_bib0540","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jconrel.2013.09.021","article-title":"ColoPulse tablets perform comparably in healthy volunteers and Crohn\u2019s patients and show no influence of food and time of food intake on bioavailability","volume":"172","author":"Maurer","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2020.06.011_bib0545","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2125.2011.04071.x","article-title":"Applications of stable isotopes in clinical pharmacology","volume":"72","author":"Schellekens","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0550","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/17425247.2017.1360864","article-title":"Enteric coatings for colonic drug delivery: state of the art","volume":"14","author":"Maroni","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.drudis.2020.06.011_bib0555","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/jps.2600801017","article-title":"A new method of dissolution in vitro, the \u2018Bio-Dis\u2019 apparatus: Comparison with the rotating bottle method and in vitro:in vivo correlations","volume":"80","author":"Esbelin","year":"1991","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0560","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(00)00649-9","article-title":"A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development","volume":"213","author":"Gupta","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0565","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/10837450.2010.485319","article-title":"Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet","volume":"16","author":"Kshirsagar","year":"2011","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0570","first-page":"803","article-title":"Pharmacokinetics of budesonide (EntocortTM EC) capsules for Crohn\u2019s disease","volume":"43","author":"Edsb\u00e4cker","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.drudis.2020.06.011_bib0575","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-5173(93)90406-6","article-title":"An in vivo investigation into the suitability of pH dependent polymers for colonic targeting","volume":"95","author":"Ashford","year":"1993","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0580","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-5173(93)90344-F","article-title":"An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting","volume":"91","author":"Ashford","year":"1993","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0585","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/gut.28.9.1084","article-title":"Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis","volume":"28","author":"Mardini","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2020.06.011_bib0590","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.2042-7158.1985.tb04962.x","article-title":"Absorption of delayed-release prednisolone in ulcerative colitis and Crohn\u2019s disease","volume":"37","author":"Thomas","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.drudis.2020.06.011_bib0595","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5173(01)00839-0","article-title":"Citric acid as excipient in multiple-unit enteric-coated tablets for targeting drugs on the colon","volume":"229","author":"Nyk\u00e4nen","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2020.06.011_bib0600","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.1992.tb00542.x","article-title":"An Eudragit-coated prednisolone preparation for ulcerative colitis: pharmacokinetics and preliminary therapeutic use","volume":"6","author":"Ford","year":"1992","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0605","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/gut.28.2.196","article-title":"Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract","volume":"28","author":"Myers","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2020.06.011_bib0610","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0928-0987(98)00032-3","article-title":"Enteric polymers as binders and coating materials in multiple-unit site-specific drug delivery systems","volume":"7","author":"Marvola","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0615","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2036.1992.tb00269.x","article-title":"A pharmacokinetic study of sulphasalazine and two new formulations of mesalazine","volume":"6","author":"Swift","year":"1991","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2020.06.011_bib0620","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejps.2006.09.004","article-title":"A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products","volume":"30","author":"Schellekens","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2020.06.011_bib0625","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0306-3623(91)90440-H","article-title":"Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules","volume":"22","author":"Gwinup","year":"1991","journal-title":"Gen. Pharmacol. Vasc. Syst."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620302361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620302361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:50:42Z","timestamp":1761223842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644620302361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":125,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1359644620302361"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2020.06.011","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"pH-dependent ileocolonic drug delivery, part I: in vitro and clinical evaluation of novel systems","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}